Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Gastroenterology. 2017 Dec 19;154(5):1290–1297.e1. doi: 10.1053/j.gastro.2017.12.006

TABLE 1.

AGE-STANDARDIZED BASELINE CHARACTERISTICS ACCORDING TO PPI USE

Nurses’ Health Study (2000) Health Professionals Follow-Up Study (2004)
Non-user (n=64,055) Regular user (n=4,459) Non-user (n=24,326) Regular user (n=4663)
Age, years 65.7 (7.1) 65.7 (7.1) 69.9 (8.6) 69.9 (8.5)
Smoking, %
 Never 45 42 53 49
 Past 46 51 44 48
Current 9 7 3 3
Exercise, mean MET-hrs/wk 17.5 (22.1) 13.9 (18.2) 45.4 (47.3) 40.4 (45.2)
BMI, kg2/mg2 26.6 (5.3) 28.3 (5.8) 25.6 (4.9) 25.9 (4.9)
Regular ASA usage, % 26 24 59 62
Regular NSAID usage, % 28 29 18 20
Past/current PMH, % 46 52 N/A N/A
AHEI score 50.0 (9.6) 49.4 (9.4) 52.4 (10.8) 51.8 (10.5)
Hypertension, % 47 63 49 60
Hyperlipidemia, % 59 73 59 68
Coronary Heart Disease, % 3 5 9 12
Diabetes Mellitus, % 8 11 10 11
GERD, % 8 37 23 72
Prior PUD, % 9 28 9 22
Prior GI bleed, % 2 6 4 8
Past/current H2RA usage, % 15 66 12 49

Values are means (SD) or percentages and are standardized to the age distribution of the study population.

MET: metabolic-equivalent task, BMI: body mass index, ASA: acetylsalicylic acid, NSAID: non-steroidal anti-inflammatory drug, AHEI: Alternative Healthy Eating Index, GERD: gastroesophageal reflux disease, PUD: peptic ulcer disease, GI: gastrointestinal, H2RA: histamine-2 receptor antagonist

Regular use of either ASA or NSAIDs defined as ≥2 tablets per week. PMH use measured only among post-menopausal females.